Man Caught Using E-Cigarette with Illegal Substance on Train

Regulations by 2FIRSTS.ai
Jan.04.2024
Man Caught Using E-Cigarette with Illegal Substance on Train
A man was caught using an e-cigarette containing illegal substance on a train in Guangzhou, China.

According to a report by China News Network on January 3, the Guangzhou railway police recently successfully apprehended a man who was using an e-cigarette containing ethyl methylphenidate in the train restroom. The individual has been subjected to administrative penalties as per the law.

 

According to reports, this incident occurred on the Z111 train running between Ganzhou and Shaoguan East. A man was found lying in the restroom by the train police, using an e-cigarette alone. He appeared to be in a dazed state and showed no reaction to the sudden arrival of the police. After being woken up and questioned by the authorities, the man admitted to the fact that the e-cigarette contained the illegal substance ethyl methylamino cyclohexane. The train police then took the man to the police station at Guangzhou Station for further processing.

 

After undergoing urine drug testing, a man named Ma (pseudonym), 21 years old, unemployed, and holder of a standing ticket from Ganzhou to Shaoguan East, was confirmed to have tested positive for methamphetamine in his urine. Furthermore, he fully admitted to his illegal actions. According to Ma's recollection, he engaged in the use of an e-cigarette containing methamphetamine in the bathroom only after his phone became unusable. He also stated that he was well aware that methamphetamine had been officially classified as a narcotic and psychoactive drug, but still succumbed to impulsiveness and tried it a couple of times, ultimately being apprehended by the police. Currently, the Guangzhou Railway Police have lawfully punished Ma and confiscated his e-cigarette device and related items.

 

Since October 1, 2023, the use of methoxyflurane has officially been included in the list of anesthetic and psychotropic drugs. Any illegal activities such as use, smuggling, trafficking, transportation, or manufacturing involving methoxyflurane will be treated as a drug-related crime and prosecuted according to the law.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Observation|VELO at Stockholm Arlanda: Travel-Centric Messaging and Full-Line Flavour Presentation
2Firsts Observation|VELO at Stockholm Arlanda: Travel-Centric Messaging and Full-Line Flavour Presentation
2Firsts observed at Stockholm Arlanda Airport that British American Tobacco’s VELO positions the airport environment as a core marketing scenario, deploying large-format LED displays, a full flavour matrix, and clear nicotine-strength segmentation. The brand also features an instructional “How to Use VELO” section and multi-pack sales strategy, showcasing its systematic merchandising capabilities in the Nordic travel-retail channel.
Nov.19 by 2FIRSTS.ai
Special Report | After the Shortage: How the U.S. Vape Market Is Rebuilding Itself
Special Report | After the Shortage: How the U.S. Vape Market Is Rebuilding Itself
After a wave of regulatory crackdowns, the U.S. vaping market is undergoing a deep reshuffle — shortages sparked frenzy, and resupply triggered elimination. Through interviews with industry insiders from both China and the United States, 2Firsts reveals how the American market is rebuilding itself amid turbulence.
Nov.12
Irish Cabinet to Consider Bill Banning Sale of Single-Use Vapes
Irish Cabinet to Consider Bill Banning Sale of Single-Use Vapes
Ireland’s Minister for Health, Jennifer Carroll MacNeill, will seek Cabinet approval today for the publication of the Public Health (Single-Use Vapes) Bill 2025, which proposes banning the retail sale of single-use or disposable vapes six months after becoming law. The measure aims to address the growing use of disposable vapes, particularly among young people, and close regulatory gaps around emerging nicotine products such as pouches.
Nov.18 by 2FIRSTS.ai
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Altria on December 19 confirmed that six on! PLUS nicotine pouch products had received U.S. FDA marketing authorization, ending a PMTA review lasting more than a year after the company moved ahead with launch plans before clearance.
Regulations
Dec.20
RLX Technology Inc. (NYSE: RLX) Q3 2025 Financial Results: Net Revenue US$158.6 Million; International Business Accounts for 72%
RLX Technology Inc. (NYSE: RLX) Q3 2025 Financial Results: Net Revenue US$158.6 Million; International Business Accounts for 72%
RLX Technology Inc. (NYSE: RLX) announced its unaudited financial results for the third quarter of 2025. The company reported net revenue of RMB 1.13 billion, up 49.3% year-on-year, and adjusted net profit of RMB 295.4 million, up 1.4% quarter-on-quarter. International business contributed 72% of total revenue, reflecting robust financial performance and continued shareholder returns.
Nov.14
Sarawak Cabinet Approves Gradual Ban on Vape Products to Curb Rising Youth Use
Sarawak Cabinet Approves Gradual Ban on Vape Products to Curb Rising Youth Use
The Sarawak Cabinet has agreed to implement a phased ban on vape products amid growing concern over rising use among youths. Welfare, Community Wellbeing, Women, Family and Childhood Development Minister Datuk Seri Fatimah Abdullah said the move demonstrates the state’s firm commitment to safeguarding young people’s health and future.
Nov.17 by 2FIRSTS.ai